Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden.

The occurrence and removal rate of seven pharmaceuticals (ibuprofen, naproxen, diclofenac, fluoxetine, ofloxacin, norfloxacin, ciprofloxacin), two metabolites (norfluoxetine, clofibric acid), one degradation product (4-isobutylacetophenone) and 3 estrogens (17alpha-ethinylestradiol, 17beta-estradiol, estrone) were studied in the inlet and outlet of a tertiary sewage treatment plant (STP) in Sweden as well as between different treatment steps in the STP which includes a conventional activated sludge step. Pharmaceuticals in raw household and raw hospital sewage streams leading to the STP were as well investigated. Hydraulic retention times (HRT) of each treatment step was considered for sampling and for the calculation of the removal rates. These rates were above 90%, except for diclofenac, clofibric acid, estrone and ofloxacin. However, only diclofenac and naproxen showed significant effluent loads (>145 mg/d/1000 inh). Diclofenac was not eliminated during the treatment and in fact even higher concentrations were found at the effluent than in the inlet of the STP. 17alpha-Ethinylestradiol was not detected in any of the samples. Results indicate that a STP such as the one in Kristianstad, Sweden, with a tertiary treatment is sufficient to remove significantly most of the investigated pharmaceuticals. The chemical treatment improved the removal of several pharmaceuticals especially the antibiotics, which showed step removal rates between 55 and 70%. The expected concentration levels of the pharmaceuticals in the surface water (dilution 1 to 10) close to the outlet of the STP are below the no-observed effect-concentration (NOEC). However, despite that this would imply no important effects in the aquatic environment one cannot rule out negative consequences nearby the STP because most of the NOEC values are derived from acute toxicity data. This may underestimate the real impact of pharmaceuticals in the aquatic ecosystem.

[1]  Klaus Kümmerer,et al.  Pharmaceuticals in the environment : sources, fate, effects and risks , 2008 .

[2]  S. Zorita,et al.  Hollow-fibre supported liquid membrane extraction for determination of fluoxetine and norfluoxetine concentration at ultra trace level in sewage samples. , 2007, Journal of separation science.

[3]  Walter Giger,et al.  Environmental exposure and risk assessment of fluoroquinolone antibacterial agents in wastewater and river water of the Glatt Valley Watershed, Switzerland. , 2002, Environmental science & technology.

[4]  N Yamashita,et al.  Removal of antibiotics from wastewater by sewage treatment facilities in Hong Kong and Shenzhen, China. , 2008, Water research.

[5]  Hideshige Takada,et al.  Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage treatment plant. , 2007, Water research.

[6]  A. Schäffer,et al.  Factors affecting the removal of organic micropollutants from wastewater in conventional treatment plants (CTP) and membrane bioreactors (MBR) , 2008 .

[7]  D. Aga,et al.  Comparison of the occurrence of antibiotics in four full-scale wastewater treatment plants with varying designs and operations. , 2007, Chemosphere.

[8]  T. Tuhkanen,et al.  Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. , 2005, Water research.

[9]  C. Adams,et al.  Potentiometric determination of acid dissociation constants (pKa) for human and veterinary antibiotics. , 2004, Water research.

[10]  T. Ternes.  Occurrence of drugs in German sewage treatment plants and rivers 1 Dedicated to Professor Dr. Klaus , 1998 .

[11]  Lennart Mathiasson,et al.  Selective determination of acidic pharmaceuticals in wastewater using molecularly imprinted solid-phase extraction. , 2008, Analytica chimica acta.

[12]  K. Fent,et al.  Ecotoxicology of human pharmaceuticals. , 2006, Aquatic toxicology.

[13]  Oliver A.H. Jones,et al.  The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilising activated sludge treatment. , 2007, Environmental pollution.

[14]  G. Thorgaard,et al.  High incidence of a male-specific genetic marker in phenotypic female chinook salmon from the Columbia River. , 2000, Environmental health perspectives.

[15]  E. Thurman,et al.  Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002, Environmental science & technology.

[16]  Jun Li,et al.  Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), South China. , 2007, Water research.

[17]  H Kroiss,et al.  Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. , 2005, Water research.

[18]  S. Zorita,et al.  Steroid hormone determination in water using an environmentally friendly membrane based extraction technique. , 2008, Journal of chromatography. A.

[19]  E. Heath,et al.  Removal of pharmaceutical residues in a pilot wastewater treatment plant , 2007, Analytical and bioanalytical chemistry.

[20]  Víctor Matamoros,et al.  Organic micropollutant removal in a full-scale surface flow constructed wetland fed with secondary effluent. , 2008, Water research.

[21]  A. Schäfer,et al.  Occurrence of pharmaceutically active and non-steroidal estrogenic compounds in three different wastewater recycling schemes in Australia. , 2007, Chemosphere.

[22]  G. Bullock,et al.  Oxytetracycline residues in a freshwater recirculating system , 2002 .

[23]  Jaeweon Cho,et al.  Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. , 2007, Water research.

[24]  M. Servos,et al.  Behavior and occurrence of estrogens in municipal sewage treatment plants--I. Investigations in Germany, Canada and Brazil. , 1999, The Science of the total environment.

[25]  S. Jørgensen,et al.  Occurrence, fate and effects of pharmaceutical substances in the environment--a review. , 1998, Chemosphere.

[26]  J. Castell,et al.  In vitro assessment of the phototoxicity of anti-inflammatory 2-arylpropionic acids. , 1991, Toxicology in vitro : an international journal published in association with BIBRA.

[27]  Adriano Joss,et al.  Removal of pharmaceuticals and fragrances in biological wastewater treatment. , 2005, Water research.

[28]  Martin Kampmann,et al.  Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater? , 2003, Water research.

[29]  T Wintgens,et al.  Removal of hormones and pharmaceuticals in the Advanced Water Recycling Demonstration Plant in Queensland, Australia. , 2004, Water science and technology : a journal of the International Association on Water Pollution Research.

[30]  D. Calamari,et al.  Removal of pharmaceuticals in sewage treatment plants in Italy. , 2006, Environmental science & technology.

[31]  K. Armbrust,et al.  Laboratory persistence and fate of fluoxetine in aquatic environments , 2006, Environmental toxicology and chemistry.

[32]  Mats Tysklind,et al.  Environmental risk assessment of antibiotics in the Swedish environment with emphasis on sewage treatment plants. , 2007, Water research.

[33]  G. Caviglioli,et al.  Identification of degradation products of ibuprofen arising from oxidative and thermal treatments. , 2002, Journal of pharmaceutical and biomedical analysis.

[34]  L. Larsson,et al.  Comparison of solid-phase sorbents for the determination of fluoroquinolone antibiotics in wastewater. , 2008, Journal of separation science.

[35]  A. Fernández-Alba,et al.  Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. , 2007, Chemosphere.

[36]  H. Kroiss,et al.  The solids retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. , 2005, Water research.

[37]  Marta Carballa,et al.  Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. , 2004, Water research.

[38]  S. Zorita,et al.  A novel hollow-fibre microporous membrane liquid-liquid extraction for determination of free 4-isobutylacetophenone concentration at ultra trace level in environmental aqueous samples. , 2007, Journal of chromatography. A.

[39]  Mira Petrovic,et al.  Advanced mass spectrometric methods applied to the study of fate and removal of pharmaceuticals in wastewater treatment , 2007 .

[40]  C. Metcalfe,et al.  Analysis of paroxetine, fluoxetine and norfluoxetine in fish tissues using pressurized liquid extraction, mixed mode solid phase extraction cleanup and liquid chromatography-tandem mass spectrometry. , 2007, Journal of chromatography. A.

[41]  Roberto Andreozzi,et al.  Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. , 2003, Chemosphere.

[42]  L. Mathiasson,et al.  Application of standard addition methodology for the determination of banned azo dyes in different leather types , 2005 .

[43]  D. Barceló,et al.  Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro river basin (Northeast Spain) , 2007, Environmental toxicology and chemistry.

[44]  T. Tuhkanen,et al.  Elimination of pharmaceuticals in sewage treatment plants in Finland. , 2007, Water research.